5qqu
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1348371854== | |
| - | + | <StructureSection load='5qqu' size='340' side='right'caption='[[5qqu]], [[Resolution|resolution]] 1.55Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[5qqu]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5QQU OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5QQU FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NTG:5-(1,4-oxazepan-4-yl)pyridine-2-carbonitrile'>NTG</scene>, <scene name='pdbligand=PLP:PYRIDOXAL-5-PHOSPHATE'>PLP</scene></td></tr> | |
| - | [[Category: | + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/5-aminolevulinate_synthase 5-aminolevulinate synthase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.3.1.37 2.3.1.37] </span></td></tr> |
| - | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5qqu FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5qqu OCA], [http://pdbe.org/5qqu PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5qqu RCSB], [http://www.ebi.ac.uk/pdbsum/5qqu PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5qqu ProSAT]</span></td></tr> |
| - | [[Category: Arrowsmith, C | + | </table> |
| + | == Disease == | ||
| + | [[http://www.uniprot.org/uniprot/HEM0_HUMAN HEM0_HUMAN]] X-linked sideroblastic anemia;Erythropoietic protoporphyria. The disease is caused by mutations affecting the gene represented in this entry. The disease is caused by mutations affecting the gene represented in this entry. Gain of function mutations in ALS2 are responsible for XLDPT, but they can also be a possible aggravating factor in congenital erythropoietic porphyria and other erythropoietic disorders caused by mutations in other genes (PubMed:21309041).<ref>PMID:21309041</ref> | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: 5-aminolevulinate synthase]] | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Arrowsmith, C H]] | ||
| + | [[Category: Bailey, H]] | ||
| + | [[Category: Bezerra, G A]] | ||
| + | [[Category: Bountra, C]] | ||
[[Category: Brandao-Neto, J]] | [[Category: Brandao-Neto, J]] | ||
| - | + | [[Category: Brennan, P E]] | |
| - | [[Category: Brennan, P | + | [[Category: Delft, F von]] |
| - | [[Category: | + | [[Category: Douangamath, A]] |
| - | [[Category: | + | |
[[Category: Edwards, A]] | [[Category: Edwards, A]] | ||
| - | [[Category: | + | [[Category: Foster, W]] |
| - | + | ||
[[Category: Krojer, T]] | [[Category: Krojer, T]] | ||
| - | [[Category: | + | [[Category: Nicola, B B]] |
| - | [[Category: | + | [[Category: Shrestha, L]] |
| - | [[Category: | + | [[Category: Talon, R]] |
| - | [[Category: | + | [[Category: Yue, W W]] |
| + | [[Category: Pandda]] | ||
| + | [[Category: Sgc - diamond i04-1 fragment screening]] | ||
| + | [[Category: Transferase]] | ||
| + | [[Category: Xchemexplorer]] | ||
Revision as of 05:43, 7 August 2019
PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1348371854
| |||||||||||
Categories: 5-aminolevulinate synthase | Large Structures | Arrowsmith, C H | Bailey, H | Bezerra, G A | Bountra, C | Brandao-Neto, J | Brennan, P E | Delft, F von | Douangamath, A | Edwards, A | Foster, W | Krojer, T | Nicola, B B | Shrestha, L | Talon, R | Yue, W W | Pandda | Sgc - diamond i04-1 fragment screening | Transferase | Xchemexplorer
